General Information
Revision date
2019-10-29
Product name
Prascend , tablets
CAS No.
66104-23-2
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user on use
Emergency telephone
+1 703-527-3887 Chemtrec 24-hours
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
Hazard Codes
Hazard statements (CLP)
H362
Hazard statements
Code
Statements
H362
May cause harm to breast-fed children
Section 2
CLP CLASSIFICATION
Effects on or via lactation H362: May cause harm to breast-fed children.
2.2 Label elements
REGULATION (EC) No 1272/2008)
Hazard statements
H362 May cause harm to breast-fed children.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe dust or mist. P263 Avoid contact during pregnancy and while nursing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Hazardous Ingredients
Pergolide methanesulfonate
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
